Market Overview

Meridian Subsidiary Bioline, Launches ISOLATE II

Bioline, The PCR Company, a wholly-owned subsidiary of Meridian
Bioscience, Inc. (NASDAQ: VIVO), is proud to announce the worldwide
release of the high performance ISOLATE II range of nucleic acid
purification kits.

Based on filter membrane spin column technology with simple
bind-wash-elute steps; the new Bioline ISOLATE II kits are designed for
fast and efficient isolation of DNA or RNA from a wide range of
biological materials. By using ISOLATE II kits, researchers can expect
higher yields, higher purity and greater reproducibility when compared
to previous generation nucleic acid purification kits.

Marco Calzavara, President of Bioline commented, “With ISOLATE II
nucleic acid purification kits, researchers can now quickly achieve

See full press release

Posted-In: News Guidance Management

 

Related Articles (VIVO)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters